A review of cutaneous anthrax and its outcome

Journal of Infection and Public Health

Volumn 3, Issue 3, 2010, Pages 98-105

  Doganay, Mehmet ^a   Metan, Gokhan ^a   Alp, Emine ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

Anthrax; Bacillus anthracis; Cutaneous anthrax; Turkey

Indexed keywords

ALBUMIN; AMOXICILLIN; CEFALEXIN; CIPROFLOXACIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; INFUSION FLUID; PENICILLIN G; PENICILLIN V; PROCAINE PENICILLIN; VASOACTIVE AGENT;

ANTHRAX; ANTIBIOTIC THERAPY; APATHY; ARTICLE; BACILLUS ANTHRACIS; BACTERIAL SKIN DISEASE; BACTERIAL TRANSMISSION; CLINICAL FEATURE; DISEASE SEVERITY; DRUG CHOICE; EDEMA; ERYTHEMA; FEVER; HUMAN; HYPOALBUMINEMIA; HYPONATREMIA; HYPOTENSION; INCUBATION TIME; LEUKOCYTOSIS; MEDICAL RECORD REVIEW; PRACTICE GUIDELINE; PRIORITY JOURNAL; SCAR; SEPTIC SHOCK; SKIN ANTHRAX; SKIN BLEEDING; SKIN DEFECT; SYSTOLIC BLOOD PRESSURE; TOXEMIA; TREATMENT DURATION; TREATMENT OUTCOME; VESICULAR RASH; WORLD HEALTH ORGANIZATION;

ADOLESCENT; ADULT; AMOXICILLIN; ANTHRAX; ANTI-BACTERIAL AGENTS; BACILLUS ANTHRACIS; CIPROFLOXACIN; DOXYCYCLINE; FEMALE; HUMANS; MALE; MIDDLE AGED; PENICILLIN G PROCAINE; TREATMENT OUTCOME; TURKEY; YOUNG ADULT;

EID: 77957019293     PISSN: 18760341     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jiph.2010.07.004     Document Type: Article

References (14)

1. Turnbull P.C.B. WHO Anthrax Working Group. Anthrax in humans and animals 2008, World Health Organization, Geneva. 4th ed.
2. Doganay M., Metan G. Human anthrax in Turkey from 1990 to 2007. Vector Borne Zoonotic Dis 2009, 9(2):131-140.
3. Doganay M. Anthrax. Infectious diseases 2010, 1257-1261. Mosby-Elsevier, China. 3rd ed. J. Cohen, S.M. Opal, W.G. Powderly (Eds.).
4. Ozkurt Z., Parlak M., Tastan R., Dinler U., Saglam Y.S., Ozyurek S.F. Anthrax in eastern Turkey, 1992-2004. Emerg Infect Dis 2005, 11:1939-1941.
5. Jernigan J.A., Stephens D.S., Ashford D.A., et al. Bioterrorism-related inhalation anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001, 7:933-944.
6. Inglesby T.V., O'Toole T., Henderson D.A., Bartlett J.G., Ascher M.S., Eitzen E., et al. Working group on civilian biodefense. Anthrax as a biological weapon. JAMA 2002, 287:2236-2252.
7. Anaraki S, Addiman S, Nixon G., et al. A case of naturally acquired inhalation anthrax in London. Bacillus-ACT 2009: the international Bacillus anthracis, B. cereus, and B. thuringiensis conference, an ASM conference 2009, Abstract number: 16 D.
8. Ramsay C.N., Stirling A., Smith J., et al. An outbreak of infection with Bacillus anthracis in injecting drug users in Scotland. Eurosurveillance 2010, 15(2).
9. Dixon T.C., Messelson M., Guillemin J., Hanna P.C. Anthrax. New Eng J Med 1999, 11:815-826.
10. Demirdag K., Ozden M., Saral Y., Kalkan A., Kilic S.S., Ozdarendeli A. Cutaneous anthrax in adults: a review of 25 cases in the eastern Anatolian region of Turkey. Infection 2003, 31:327-330.
11. Kaya A., Tasyaran M.A., Erol S., Ozkurt Z. Anthrax in adults and children: a review of 132 cases in Turkey. Eur J Clin Microbiol Infect Dis 2002, 21:258-261.
12. Tasyaran M.A., Deniz O., Ertek M., Cetin K. Anthrax meningitis: case report and review. Scan J Infect Dis 2002, 34:66-67.
13. Smego R.A., Gebrian B., Desmangels G. Cutaneous manifestations of anthrax in rural Haiti. Clin Infect Dis 1998, 26:97-102.
14. Doganay M., Baki{dotless}r M., Dokmetas I. A case of cutaneous anthrax with toxaemic shock. Br J Dermatol 1987, 117:659-662.